Reducing Drug Spend with IV Robotic Services
Sr. Director, Central Pharmacy Product Marketing, Omnicell
IV automation technology combined with robust expert services is a game-changer for reducing drug spend while enhancing patient safety.
The number of improperly prepared IVs is staggering. Studies have shown that one out of every ten can put patients at risk. Sterile compounding is also one of the costliest functions in pharmacy operations. Still, many hospital pharmacies continue to struggle to improve safety and efficiency in their sterile compounding operations.
Some health systems have turned to IV compounding robots to enhance patient safety while reducing OR medication waste and reliance on 503B outsourcers. Moses H. Cone Memorial Health was an early adopter of IV robotic technology and blazed a trail for other health systems to follow.
I'm excited to join Kevin Hansen, Assistant Director of Pharmacy at Moses H. Cone Memorial Health in Greensboro, North Carolina, during this year's Omnicell Omnicell Illuminate 2021 virtual event to discuss how IV automation technology combined with robust expert services is a game-changer for improving sterile compounding operations while reducing drug spend.
During this CE-accredited session, scheduled for Tuesday, Oct. 5 at 2 p.m. EDT (11 a.m. PDT), Dr. Hansen will share his experience in implementing a strategic plan to adopt sterile compounding technology to benefit patient safety and overall hospital operations.
Insourcing IV compounding services at Moses H. Cone Memorial Health delivered substantial value and cost savings for the health system. Automating tasks that were previously done manually allowed Moses H. Cone Memorial Health to reduce errors while providing consistent service levels around the hospital's busiest times.
It's imperative that pharmacy leaders demonstrate how these systems are helping them conveniently deliver high-quality medications, supporting critical patient care needs with precision and speed.
By reducing drug spend with IV robotic services, Moses H. Cone Memorial Health was able to realize significant improvements in savings, safety, efficiency, and financial outcomes by:
- Ensuring the highest quality and safety of compounded sterile preparations
- Providing ready-to-administer products where FDA premixes don't exist
- Maintaining a consistent supply chain of ready-to-administer products
- Delivering flexible product preparation to meet patient needs
- Streamlining label production for safety and compliance
- Driving cost savings to fund other automation projects
Join Dr. Hansen and me on Tuesday, Oct. 5 at 2 p.m. EDT (11 a.m. PDT) to learn how you can reduce drug spend by implementing IV robotic services to insource sterile compounding operations at your healthcare facility.
Register today at Omnicell Illuminate 2021.